The global artificial intelligence in oncology market was valued at USD 3.23 Billion in 2025, driven by the rising demand for early and accurate cancer detection and increasing integration of AI in drug discovery and personalized cancer treatment planning across the globe. The market is anticipated to grow at a CAGR of 28.60% during the forecast period of 2026-2035, with the values likely to reach USD 39.96 Billion by 2035. The market is fueled by the growing adoption of AI in diagnostics and treatment workflows. Expansion of precision oncology and increasing investment in healthcare AI technologies are expected to boost market growth.
Base Year
Historical Period
Forecast Period
According to the American Cancer Society, lung cancer is expected to cause 226,650 new cases and 124,730 deaths in the U.S. by 2025. This growing cancer burden is significantly accelerating the adoption of AI in oncology.
In June 2024, Better Medicine launched BMVision Kidney, the first CE-certified AI solution for kidney cancer detection. Such advancements are propelling early diagnosis capabilities and significantly driving growth in the global AI in oncology market.
One of the major market trends includes the development of multifunctional AI tools for oncology. For instance, in September 2024, Harvard Medical School introduced CHIEF, an AI model that accurately diagnoses cancer, predicts survival, and guides treatment decisions.
Compound Annual Growth Rate
28.6%
Value in USD Billion
2026-2035
*this image is indicative*
Artificial intelligence (AI) is transforming oncology by enhancing diagnostic accuracy, streamlining workflows, and supporting personalized treatment approaches. Its integration across clinical and research settings is driving significant improvements in cancer care efficiency and outcomes. The market is experiencing rapid growth and is poised to reach USD 39.96 Billion by 2035, due to the increasing cancer burden, expanding healthcare digitization, and rising demand for precision medicine. Technological advancements and growing investments in AI-driven healthcare solutions are further propelling market expansion.
Rising Cancer Incidence to Drive the Demand for AI in Oncology
The rising global cancer burden serves as a critical growth driver for the market. According to Rebecca L. Siegel et al., in February 2025, an estimated 2,041,910 new cancer cases and 618,120 cancer deaths are expected in the United States alone. This surge in incidence highlights the urgent need for faster, more accurate diagnostic and therapeutic solutions. AI technologies offer enhanced precision and efficiency, driving their increasing integration into oncology practices and fueling substantial market expansion.
The market is witnessing several emerging trends, including the development of breakthrough AI models to enhance predictive accuracy and the growing integration of AI-human collaboration in drug discovery.
Rise in Breakthrough AI Models to Improve the Predictive Accuracy in Oncology
The market is witnessing a significant technological shift with the integration of advanced predictive models. In April 2025, Onc.AI presented its FDA breakthrough-designated Serial CT Response Score (CTRS) model at the AACR Annual Meeting. Evaluated using GSK’s clinical trial data in non-small cell lung cancer (NSCLC). The AI model outperformed traditional assessment tools like RECIST 1.1 and tumor volume changes in predicting overall survival. This development underscores the growing impact of AI-driven imaging solutions in early treatment evaluation. The adoption of such innovative tools is expected to accelerate clinical decision-making and propel market growth.
AI-Human Collaboration in Drug Discovery Set to Enhance Artificial Intelligence in Oncology Market Demand
The growing collaboration between AI models and human researchers to identify novel cancer treatments is a notable trend in the market. In June 2025, scientists at the University of Cambridge employed GPT-4 to analyze scientific literature and propose unconventional, non-cancer drug combinations to combat breast cancer. This closed-loop system, where AI-driven insights informed and evolved through laboratory testing, resulted in six promising drug pairs, showcasing AI’s ability to accelerate oncological innovation. This pioneering synergy is likely to enhance market growth.
Breast Cancer Expected to Lead the Market by Cancer Type
As artificial intelligence transforms the oncology landscape, its impact varies across cancer types. The market is segmented into breast cancer, lung cancer, colorectal cancer, brain cancer, leukemia, lymphoma, and others. Among these, breast cancer is poised to lead the AI in oncology market, driven by its overwhelming prevalence and the urgent need for precise, early-stage diagnostics. With breast cancer accounting for nearly 30% of all new cancer cases in U.S. women and over 316,000 projected diagnoses in 2025 alone, the integration of AI tools, particularly in imaging, risk prediction, and treatment planning, is gaining significant momentum. This convergence of technology and clinical urgency positions breast cancer at the forefront of innovation in AI-based oncology solutions.
The market is divided into regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Among these, North America is projected to lead, driven by cutting-edge research, strong healthcare infrastructure, and early technology adoption. In June 2025, researchers from Memorial Sloan Kettering Cancer Center, UCSF, and UC Berkeley developed DeepHeme, an AI-powered diagnostic tool that automates blood cancer analysis with expert-level accuracy. This innovation significantly reduces diagnostic time and supports precision medicine. North America's proactive digital pathology initiatives underscore its pivotal role in advancing AI-driven cancer care and research globally.
The artificial intelligence in oncology market research report by Expert Market Research provides an in-depth analysis of the competitive landscape, offering key insights into patent filings, grant analysis, funding trends, investments, and strategic initiatives by major players. It tracks recent investments, mergers, acquisitions, and partnerships that showcase the market's growth trajectory. Additionally, the report details strategic activities by leading companies, including regional expansions, adoption of new technologies, and efforts to enhance capacity, helping stakeholders better understand the market dynamics and positions of key industry players. Some of the leading players are as follows:
Aidoc, a global leader in clinical artificial intelligence, has strengthened its role in the market through its expanded partnership with Integral Diagnostics (IDX) in Australia and New Zealand. Leveraging its aiOS™ platform, Aidoc enhances radiologists’ workflows by detecting critical pathologies such as lung nodules, aiding early cancer diagnosis. Its AI integration supports the upcoming National Lung Cancer Screening Program, reinforcing Aidoc's commitment to advancing oncology care through AI-driven medical imaging solutions.
iCAD, Inc. is a leading medical technology company specializing in Artificial Intelligence solutions for cancer detection and risk assessment, with a strong focus on breast oncology. Its ProFound Breast Health Suite, comprising detection, density, and risk tools, leverages AI to identify invasive cancers earlier and more accurately. iCAD's involvement in the artificial intelligence in oncology market emphasizes improving diagnostic efficiency, patient outcomes, and survival rates through clinically proven, AI-powered technologies.
Microsoft Corporation is significantly advancing artificial intelligence in oncology through its Azure-powered support for CancerCenter.AI. The platform enables rapid digitization and AI analysis of pathology and radiology scans, expediting cancer diagnostics and reducing errors. By integrating imaging tools and remote collaboration capabilities, Microsoft’s technology enhances diagnostic accuracy, supports faster treatment planning, and addresses the global shortage of oncology specialists.
CancerCenter.ai is a digital platform specializing in artificial intelligence solutions for oncology. It offers web-based tools for pathology and radiology image analysis, leveraging AI algorithms for tasks such as Gleason scoring, metastasis detection, and Ki-67 indexing. Its PathoCam innovation enables cost-effective slide digitization, enhancing diagnostic accuracy and workflow efficiency. The company plays a pivotal role in advancing AI-driven cancer diagnosis globally.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Mursla Bio, SkinVision, Kheiron Medical Technologies Limited, Therapixel, Tempus AI, Inc., and Paige AI Inc., among others.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Offerings
Market Breakup by Technology
Market Breakup by Application
Market Breakup by Cancer Type
Market Breakup by End User
Market Breakup by Region
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Offerings |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Cancer Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share